Navigation Links
XCHC Releases Worldwide Growth Guidance For Its Cannabinoid Treatment Centers and Formulations Targeting Critical Human Ailments, Company Acts on Own Guidance
Date:2/21/2013

DALLAS, Feb. 21, 2013 /PRNewswire/ -- X-Change Corp. (NASDAQ OTC: XCHC), a patient based U.S. company targeting critical and non-critical ailments through the use of Cannabinoid based formulations, extracts, and products through multiple Phytiva Brand product lines and solutions, is pleased to release its analysis of the worldwide market potential for medical Cannabinoid treatments of critical ailments and acute disease. 

The amount of money needed on a worldwide basis for treating critical and non-critical ailments is unnecessary, wasteful, and inhumane. The Company's near-term, global mission is to advance affordable and effective treatment solutions for a wide variety of ailments, as outlined below, using Cannabinoids. A comparative cost analysis shows a dramatic difference in treatment cost for most ailments between the status quo and the Company's approach.
Therefore, the Company intends to use this massive differential, which is essentially a large profit base, through which to expand operations by opening multiple treatment facilities locally and internationally at a rapid rate.

The Company has already publicly launched two initiatives with its Phytiva Brand European Cannabinoid product line and its Cannabinoid treatment-based facility development agreement with the Maliseet Nation in Eastern Canada.

These are two examples of the Company's targeted investments demonstrating a solid commitment to innovation in seizing opportunities in the quickly emerging Cannabinoid based treatment market. And the market opportunities are substantial:AIDS$12.6In 2010, $12.6 billion treatment market. TechNavio's analysts forecast the global HIV drug market to reach $15.5 billion by 2014.Alzheimer's$8.3The global Alzheimer's disease treatment market was valued at $8.3 billion in 2010 and estimated to be $9.0 billion by 2016.Anti-Aging$50.0With annual estimates nearing $50 billion a year, the m
'/>"/>

SOURCE X-Change Corp.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. ECRI Institute Releases C-Suite Watch List of Top 10 Hospital Technology Issues for 2013
2. Medical Marijuana, Inc. Releases 2012 Annual Share Holders Report and First Ever Corporate Revenue Forecasts
3. Drugs.com Releases Q4 Sales for Top 100 U.S. Drugs
4. Techne Corporation Releases Unaudited Second Quarter And Six Month Fiscal Year 2013 Results
5. CBIS Releases Corporate Operational Guidance for 2013 as the Company Reorganizes to better meet the Growing Global Crisis Associated with Anti-Retroviral Drug Resistance among People with AIDS, as well as the Increasing Need for Patient Friendly Ski
6. MDHI to Hold Conference Call Thursday, Jan 31st to Discuss Business Growth and Positive Cash Flow - Releases Additional Financial Results
7. MDHI Releases Fiscal 2012 Financials - Updates Financial Disclosures
8. Drugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But Nexium and Abilify Remain the Leading Brands
9. Hitachi Aloka Medical Releases Noblus, Advanced Versatile Ultrasound with Flexible Style
10. New England Biolabs Releases a New Fast, Low-Nanogram Input Library Prep Method for DNA and RNA Sequencing
11. Cephasonics Releases Ultrasound API Software Version 3.0
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... -- Cellular Biomedicine Group (OTCQB: CBMG) today announced that it ... enrollment required for its Phase I trial to evaluate the ... Dendritic Cell) therapy for hepatocellular carcinoma (HCC), the most common ... no Severe Adverse Effect (SAE) reported. The Phase ... NIH under number NCT01828762 (click here to view) ...
(Date:5/22/2013)... May 22, 2013 PRNewswire – iBio, ... of a vaccine candidate for the newly emerged ... laboratory using the iBioLaunch™ platform. This validation milestone ... initial antigen sequence information to purification of recombinant ... ) The iBioLaunch platform eliminates the ...
(Date:5/22/2013)... TEL AVIV, Israel , May 22, 2013 /PRNewswire/ ... "Company") (TASE, NASDAQ: EMITF) announced today, further to the ... filed a motion with the Tel Aviv ... of its unsecured creditors and shareholders for the approval ... debt pursuant to a plan of arrangement (the "Arrangement") ...
Breaking Medicine Technology:Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer 2Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer 3iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza 2Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court 2Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court 3
... Pa., Aug. 24, 2011 ePharmaSolutions announced the successful ... for a top five global pharmaceutical company on more ... client deployment scheduled for September 2011. Clinical ... process for sponsors, study sites and third party vendors ...
... Fla., Aug. 24, 2011 China Nuvo Solar ... various sales channels are all reporting success that is ... lines. The Company,s plan of action to sell through ... with medical co-ops and other third party outsourcing solutions ...
Cached Medicine Technology:ePharmaSolutions Announces the Deployment of its Enterprise Clinical Trial Portal for Two Global Biopharmaceutical Companies 2China Nuvo Solar Target Acquisition SurgLine Reports on Marketing Progress 2China Nuvo Solar Target Acquisition SurgLine Reports on Marketing Progress 3
(Date:5/22/2013)... 22, 2013 GS1 has honored Tim ... Company, and Danny Wegman, CEO, Wegmans Food Markets, ... General Assembly and Global Leadership Summit, held May 20-23 ... were recognized for their outstanding contributions to the advancement ... used supply chain standards globally. , “The leadership, ...
(Date:5/22/2013)... and teens exposed to radiation during CT scans are ... a large, long-term study. The risks, however, are ... who each had one CT scan, only about six ... years, according to researchers from Australia and Europe. ... to patients when making decisions about CT (computed tomography) ...
(Date:5/22/2013)... This news release is available in German . ... Forschungsgemeinschaft (DFG, German Research Foundation) is establishing 11 new ... in Germany. This decision was made by the relevant ... euros has been awarded to the new programmes for ... In addition to the 11 new Research Training Groups, ...
(Date:5/22/2013)... to finish the last ounce in their bottle might be ... burn off, a bad habit remains. , Brigham Young University ... obesity at 24 months of age strongly traces back to ... it puts you on a trajectory where you are likely ... an adult," said Forste. "That,s a big concern." , The ...
(Date:5/22/2013)... May 22, 2013 The new 13-valent pneumococcal ... the previous version used prior to 2010, the 7-valent ... study published today in Vaccine . , The ... beginning in 2010 after a series of trials. These ... range of pneumococcal types than the previously used PCV7, ...
Breaking Medicine News(10 mins):Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 3Health News:Children Who Have CT Scans May Face Higher Cancer Risk 2Health News:DFG establishes 11 new research training groups 2Health News:DFG establishes 11 new research training groups 3Health News:DFG establishes 11 new research training groups 4Health News:DFG establishes 11 new research training groups 5Health News:Overeating learned in infancy, study suggests 2Health News:Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine 2
... Concerns of citizens over the poisonous vegetables found in ... voluntary registration system// for local farms. Additionally, supermarket chains ... a comprehensive tracking system for farm produce, according to ... system has been pointed out by a Hong Kong's ...
... Gen. Nadeem Ahmed, deputy chairman, Earthquake Rehabilitation and ... that would enable Pakistan recover from the devastating ... be completed within a year, covering some reconstruction ... distribution system, water and sanitation system, skill training, ...
... Pramod Mahajan is currently critical after being shot by his ... residence.// Pramod is currently being ventilated in the Intensive Care ... , ,Mr.Mahajan, a known diabetic received four bullets which ... at close range and went through the liver, shattering its ...
... Cancer Screening Programme, which will cover the country over the ... welcomed the introduction of this program. ... is now official that funds are being made available for ... the President of the Society as well as the Director ...
... appoint a senior nurse so that the elderly are treated ... by the government. // Ministers said there would be an ... patients in the hospitals. <br,Professor Ian Philp, the government's ... subjected to rigorous checks in order to ensure that they ...
... Piper, a New Zealander says that he was forced to take ... wife received her medications. // He says the local DHB began ... to take her from the hospital unless provided with the drug. ... only one, which controls her nausea. The Hawke's Bay hospital refused ...
Cached Medicine News:Health News:Review of Pramod Mahajan's Injuries 2
BD Visitec IOL Manipulator (Sinskey), blunt tip angled 45, 15.0 mm from end, fits 0.20 mm diameter holes and larger (3/bx, 1 bx/ca), sterile. For positioning intraocular lenses. Sure grip handles han...
Hunkeler lens manipulator, angled. Also available in titanium....
Sinskey lens manipulator, straight. Also available in titanium....
ICL manipulator with textured hemi-ball tip...
Medicine Products: